Your browser doesn't support javascript.
loading
DrugVirus.info 2.0: an integrative data portal for broad-spectrum antivirals (BSA) and BSA-containing drug combinations (BCCs).
Ianevski, Aleksandr; Simonsen, Ronja M; Myhre, Vegard; Tenson, Tanel; Oksenych, Valentyn; Bjørås, Magnar; Kainov, Denis E.
Afiliação
  • Ianevski A; Department of Clinical and Molecular Medicine (IKOM), Norwegian University of Science and Technology (NTNU), 7028 Trondheim, Norway.
  • Simonsen RM; Department of Clinical and Molecular Medicine (IKOM), Norwegian University of Science and Technology (NTNU), 7028 Trondheim, Norway.
  • Myhre V; Department of Clinical and Molecular Medicine (IKOM), Norwegian University of Science and Technology (NTNU), 7028 Trondheim, Norway.
  • Tenson T; Institute of Technology, University of Tartu, 50411 Tartu, Estonia.
  • Oksenych V; Institute of Clinical Medicine, University of Oslo, 0318 Oslo, Norway.
  • Bjørås M; Department of Clinical and Molecular Medicine (IKOM), Norwegian University of Science and Technology (NTNU), 7028 Trondheim, Norway.
  • Kainov DE; Department of Microbiology, Oslo University Hospital and University of Oslo, 0424 Oslo, Norway.
Nucleic Acids Res ; 50(W1): W272-W275, 2022 07 05.
Article em En | MEDLINE | ID: mdl-35610052
ABSTRACT
Viruses can cross species barriers and cause unpredictable outbreaks in man with substantial economic and public health burdens. Broad-spectrum antivirals, (BSAs, compounds inhibiting several human viruses), and BSA-containing drug combinations (BCCs) are deemed as immediate therapeutic options that fill the void between virus identification and vaccine development. Here, we present DrugVirus.info 2.0 (https//drugvirus.info), an integrative interactive portal for exploration and analysis of BSAs and BCCs, that greatly expands the database and functionality of DrugVirus.info 1.0 webserver. Through the data portal that now expands the spectrum of BSAs and provides information on BCCs, we developed two modules for (i) interactive analysis of users' own antiviral drug and combination screening data and their comparison with published datasets, and (ii) exploration of the structure-activity relationship between various BSAs. The updated portal provides an essential toolbox for antiviral drug development and repurposing applications aiming to identify existing and novel treatments of emerging and re-emerging viral threats.
Assuntos

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Antivirais / Vírus / Bases de Dados de Produtos Farmacêuticos Limite: Humans Idioma: En Ano de publicação: 2022 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Antivirais / Vírus / Bases de Dados de Produtos Farmacêuticos Limite: Humans Idioma: En Ano de publicação: 2022 Tipo de documento: Article